BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $122 | -21.8% | 3,253 | -5.5% | 0.01% | -22.2% |
| Q2 2023 | $156 | -0.6% | 3,443 | -11.0% | 0.01% | -10.0% |
| Q1 2023 | $157 | -10.3% | 3,868 | +12.3% | 0.01% | -16.7% |
| Q4 2022 | $175 | -99.9% | 3,443 | -12.7% | 0.01% | -20.0% |
| Q3 2022 | $213,000 | -30.8% | 3,946 | -18.0% | 0.02% | -31.8% |
| Q2 2022 | $308,000 | -17.4% | 4,813 | 0.0% | 0.02% | -8.3% |
| Q1 2022 | $373,000 | -7.2% | 4,813 | +3.0% | 0.02% | -4.0% |
| Q4 2021 | $402,000 | +2.0% | 4,671 | -4.5% | 0.02% | -3.8% |
| Q3 2021 | $394,000 | 0.0% | 4,891 | 0.0% | 0.03% | 0.0% |
| Q2 2021 | $394,000 | -4.4% | 4,891 | 0.0% | 0.03% | -7.1% |
| Q1 2021 | $412,000 | +8.7% | 4,891 | +3.7% | 0.03% | 0.0% |
| Q4 2020 | $379,000 | +1.1% | 4,718 | +1.0% | 0.03% | -9.7% |
| Q3 2020 | $375,000 | -4.6% | 4,673 | +2.4% | 0.03% | -11.4% |
| Q2 2020 | $393,000 | +1.3% | 4,563 | -4.5% | 0.04% | -14.6% |
| Q1 2020 | $388,000 | -3.0% | 4,776 | 0.0% | 0.04% | +10.8% |
| Q4 2019 | $400,000 | -4.1% | 4,776 | 0.0% | 0.04% | -9.8% |
| Q3 2019 | $417,000 | +6.6% | 4,776 | 0.0% | 0.04% | +2.5% |
| Q2 2019 | $391,000 | -27.3% | 4,776 | -27.9% | 0.04% | -31.0% |
| Q1 2019 | $538,000 | +23.4% | 6,622 | 0.0% | 0.06% | +13.7% |
| Q4 2018 | $436,000 | -15.2% | 6,622 | -0.7% | 0.05% | -8.9% |
| Q3 2018 | $514,000 | +7.8% | 6,669 | +3.3% | 0.06% | +1.8% |
| Q2 2018 | $477,000 | +7.4% | 6,454 | -5.5% | 0.06% | +1.9% |
| Q1 2018 | $444,000 | +0.9% | 6,831 | +0.4% | 0.05% | 0.0% |
| Q4 2017 | $440,000 | +6.8% | 6,807 | +3.8% | 0.05% | -3.6% |
| Q3 2017 | $412,000 | +5.4% | 6,559 | +1.5% | 0.06% | -1.8% |
| Q2 2017 | $391,000 | +130.0% | 6,459 | +97.2% | 0.06% | +111.1% |
| Q1 2017 | $170,000 | +17.2% | 3,276 | 0.0% | 0.03% | +12.5% |
| Q4 2016 | $145,000 | -7.1% | 3,276 | 0.0% | 0.02% | -14.3% |
| Q3 2016 | $156,000 | +5.4% | 3,276 | 0.0% | 0.03% | 0.0% |
| Q2 2016 | $148,000 | +10.4% | 3,276 | 0.0% | 0.03% | +7.7% |
| Q1 2016 | $134,000 | +17.5% | 3,276 | +10.1% | 0.03% | +8.3% |
| Q4 2015 | $114,000 | +10.7% | 2,976 | -5.1% | 0.02% | +9.1% |
| Q3 2015 | $103,000 | -64.7% | 3,136 | -25.0% | 0.02% | -62.1% |
| Q2 2015 | $292,000 | -17.7% | 4,180 | -19.3% | 0.06% | -17.1% |
| Q1 2015 | $355,000 | -6.6% | 5,180 | 0.0% | 0.07% | -11.4% |
| Q4 2014 | $380,000 | +2.2% | 5,180 | 0.0% | 0.08% | +5.3% |
| Q3 2014 | $372,000 | -0.8% | 5,180 | -0.0% | 0.08% | +1.4% |
| Q2 2014 | $375,000 | -1.6% | 5,181 | 0.0% | 0.07% | -2.6% |
| Q1 2014 | $381,000 | +5.8% | 5,181 | 0.0% | 0.08% | +4.1% |
| Q4 2013 | $360,000 | +30.9% | 5,181 | +23.9% | 0.07% | +15.9% |
| Q3 2013 | $275,000 | -5.2% | 4,181 | 0.0% | 0.06% | -8.7% |
| Q2 2013 | $290,000 | – | 4,181 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |